How to interpret the new QuantiFERON- TB Gold Plus test (QFT-Plus)

Similar documents
TB Intensive Tyler, Texas December 2-4, 2008

Peggy Leslie-Smith, RN

Didactic Series. Latent TB Infection in HIV Infection

TB Intensive San Antonio, Texas November 11 14, 2014

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

TB Skin Test Practicum Houston, Texas Region 6/5 South September 23, 2014

LIAISON QuantiFERON -TB Gold Plus Solution

Technical Bulletin No. 172

Identifying TB co-infection : new approaches?

TB Intensive Houston, Texas October 15-17, 2013

Investigation of false-positive results by the QuantiFERON-TB Gold In-Tube assay

Didactic Series. Latent TB Infection in HIV Infection

Diagnosis Latent Tuberculosis. Disclosures. Case

Evaluation and Treatment of TB Contacts Tyler, Texas April 11, 2014

2016 OPAM Mid-Year Educational Conference, Sponsored by AOCOPM Sunday, March 13, 2016

Targeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease

Approaches to LTBI Diagnosis

LATENT TUBERCULOSIS. Robert F. Tyree, MD

Barbara J Seaworth MD Medical Director, Heartland National TB Center Professor, Internal Medicine and Infectious Disease UT Health Northeast

Preventing Tuberculosis (TB) Transmission in Ambulatory Surgery Centers. Heidi Behm, RN, MPH TB Controller HIV/STD/TB Program

Effect of prolonged incubation time on the results of the QuantiFERON TB Gold In-Tube assay for the diagnosis of latent tuberculosis infection

The Challenges and Pitfalls in Diagnosing or Misdiagnosing Tuberculosis: Are the Days of TB Skin Tests Over?

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection (LTBI) Lloyd Friedman, M.D. Milford Hospital Yale University

Testing for TB. Bart Van Berckelaer Territory Manager Benelux. Subtitle

Detecting latent tuberculosis using interferon gamma release assays (IGRA)

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

CHILDHOOD TUBERCULOSIS: NEW WRINKLES IN AN OLD DISEASE [FOR THE NON-TB EXPERT]

CUSOM Student Health Immunization Requirements

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis

Testing & Treatment for TB Infection: Blood Tests, Skin Tests, Who to Screen & Who to Treat?

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB

Self-Study Modules on Tuberculosis

Student Health Requirements Master of Arts, Biomedical Sciences Program

Screening of HIV-Infected Patients with IGRAs for LTBI. Background. Tuberculosis is the most prevalent in the world.

Diagnosis and Medical Case Management of Latent TB. Bryan Rock, MD April 27, 2010

Rutgers School of Nursing Center for Professional Development 65 Bergen Street, Room Newark, New Jersey 07107

Using Interferon Gamma Release Assays for Diagnosis of TB Infection

Summary of Immunization Options

Proposed Regs.pdf

Conflict of Interest Disclosures:

Clinical Passport Tutorial

Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010

QuantiFERON-TB Gold Plus

Making the Diagnosis of Tuberculosis

Tuberculosis What you need to know. James Zoretic M.D., M.P.H. Regions 2 and 3 Director

Latent Tuberculosis Infection Controversies in Diagnosis and Management of LTBI

Tuberculosis Update. Topics to be Addressed

Evaluation and Management of the Patient with Latent Tuberculosis Infection (LTBI)

TB in Corrections Phoenix, Arizona

ECHO-Antibiotic Stewardship Program

Clinical Passport Tutorial

Utility of PPD or IGRA to answer the age old question of "TB or not TB

Director, University Health Services. Medical Director

Comparison of Quantiferon-TB Gold With Tuberculin Skin Test for Detecting Latent Tuberculosis Infection Prior to Liver Transplantation

Evaluation of an In Vitro Assay for Gamma Interferon Production in Response to Mycobacterium tuberculosis Infections

Dear USC Visiting Student,

Screening for Tuberculosis Infection. Harlingen, TX. Linda Dooley, MD has the following disclosures to make:

QuantiFERON-TB Gold In-Tube Test for Tuberculosis Prevention in HIV-Infected Patients

IGRA Test Reliability. How Test Design and Lab Control Impact Results

Laboratory Updates on IGRA Testing

ATS/CDC Guidelines for Treating Latent TB Infection

Dear New USC Student,

Psoriasis and Psoriatic Arthritis Combined Clinic Electronic Medical Records Form

Questions and Answers About

Evidence-based use of the new diagnostic tools for TB-infection

Adachi et al. SpringerPlus 2013, 2:440 a SpringerOpen Journal

Charles Krasner, M.D. University of NV, Reno School of Medicine Sierra NV Veterans Affairs Medical Center

Use of Interferon-γ Release Assays (IGRAs) in TB control in low and middle-income settings - EXPERT GROUP MEETING -

Your completed Health Record and any laboratory results must be uploaded to the Student Health Portal at: shac.usciences.edu

The Prevalence and Risk Factors of Latent Tuberculosis Infection among Health Care Workers Working in a Tertiary Hospital in South Korea

Interpretation of TST & IGRA results. Objectives

Comparison of Tuberculin Skin test and Quantiferon immunological assay for latent Tuberculosis infection

Latent TB Infection (LTBI) Strategies for Detection and Management

Table 9. Policy for Tuberculosis Surveillance and Screening

Dear New USC Health Science Campus Student,

New Approaches to the Diagnosis and Management of Tuberculosis Infection in Children and Adolescents

Prevalence of Latent Tuberculosis Infection among Health Care Workers in South Korea: A Multicenter Study

LTBI-Tuberculin skin test. T-Spot.TB Technology. QuantiFERON -TB Gold In Tube T-SPOT.TB ELISA ELISA

Prevalence and risk factors of latent tuberculosis infection among health care workers in Malaysia

Diagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, TB Nurse Case Management September 12 14, 2017

Tuberculin Skin Test (TST) and Interferon-gamma Release Assays (IGRA)

Identification of latent tuberculosis infection in rheumatic patients under consideration for treatment with anti-tnf-α agents

DEPARTMENT OF THE ARMY OFFICE OF THE SURGEON GENERAL 5109 LEESBURG PIKE FALLS CHURCH, VA

Immediate Incubation Reduces Indeterminate Results for QuantiFERON-TB Gold In-Tube Assay

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

MUSC Student Pre-Matriculation Requirements Instructions for Completion of Form

Explanation of requirements for clinical experiences HFU

Tuberculin Skin Test (TST) and Interferon-gamma Release Assays (IGRA)

Dear New USC Health Science Campus Student,

TB Intensive. San San Antonio, Texas. December 1-3, 2010

TB Prevention Who and How to Screen

Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients

Role of the Laboratory in TB Diagnosis and Management

Diagnosis of Tuberculosis Infection and Disease

Michael J. Huey, MD. NYSCHA Annual Meeting WE-2, October 19, 2016

ORIGINAL ARTICLE. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients

Update on IGRA Predictive Value

Contracts Carla Chee, MHS May 8, 2012

Diagnosis and Management of Latent TB Infection Douglas Hornick, MD September 27, 2011

Transcription:

How to interpret the new QuantiFERON- TB Gold Plus test (QFT-Plus) Charles Krasner M.D. ECHO -Antibiotic Stewardship Program UNSOM Sierra NV Veterans Affairs Med Center January 17, 2019

γ-interferon is an inflammatory messenger that causes the induration seen in a positive PPD and is measured by the QFT-Gold Plus test

Up till now, PPD and γ-interferon tests did not differentiate between latent and active TB- this has been solely a clinical evaluation

Up till now, only CD4 cells (Helper cells) were tested by γ- interferon tests. The new QTF Gold Plus test now looks at not only CD4, but also CD8 response after TB antigen exposure. CD4 (Helper) cells if they recognize TB antigens- will secrete γ interferon. This response does not tell us anything about disease activity- just a Yes or No answer. A positive response still needs a clinical evaluation to determine infection versus active disease. The new Quantiferon Gold Plus test for the first time also tests CD8 cell response to TB antigens these killer cells only get activated and secrete γ interferon in the presence of recent infection or active disease. Unlike the persistent positive CD4 cell response, if the infection is old and not active- CD8 cells shut off and do not secrete γ interferon.

Summary- how to interpret the QFT-Plus test The Nil control baseline γ- interferon level- should be low, immune system not activated. Must be <8 to make test interpretable, usually near 0. Mitogen control- stimulates all CD4 cells to produce γ- interferon. Are they heathy enough to react, and was the test set up properly? Or are the cells either deteriorated or is the immune system so compromised there is no immune response? Need Mitogen-Nil value >0.5 to allow for proper test interpretation TB1 Antigen- exposes CD4 (helper cells) to 2 proteins only found in TB and sees if immune system recognizes them and secretes γ- interferon. Similar to TB test tube result in prior Quantiferon Gold test (3 rd generation test). TB1-Nil >0.35 is interpreted as positive TB2 Antigen- now exposes not only CD4 cells but also CD8 (Killer cells) to proteins only found in TB. So we now not only see the CD4 cell response, but it also throws in CD8 response. CD8 response is usually only significant when recent exposure to TB or with active disease, and declines with treatment. TB2- Nil > 0.35 is interpreted as positive. However, the greater the TB2- TB1 difference, reflecting CD8 activity (particularly if >0.6 iu)- the more likely new infection or active disease may be present.

The QFT-plus test is interpreted as positive even if only one of the two TB tubes are > 0.35 iu. This increases sensitivity but in low risk patients this may be a false positive

Interpretation?

HCW with a false positive QFT-plus on routine yearly testing Previously neg. QFT-Gold and repeat QFT- Plus was also negative

Any concerns?

Is this LabCorp interpretation correct?

Is this Renown lab interpretation correct?

Why factors may cause an equivocal result?

Highlights of the New QFT- Plus Test This new test allows blood to be drawn in only one tube, and the test doesn t have to be rushed to lab same day CD4 cells recognize TB, whether or not disease is active or old The TB1 tube tests CD4 activity only- a positive result tells you the patient has been exposed to Tuberculosis- but tells you nothing about Latent vs Active infection CD8 cells are immune cells that are only active in new or active infections, and turn off in old or inactive infection (latent TB) In Tube 2, CD4 cells are now tested with CD8 cells- giving you some idea if this TB infection is actually recent or active. The greater the difference between TB2 and TB1 (reflecting activated CD8 cells), the more likely this is possible. Be careful look at control values (nil and mitogen) first to be sure test is interpretable, then look at TB1 and TB2 tubes Low risk patients- if only one of the 2 TB tubes are positive- worth repeating test as likely a false positive result. Maybe these patients shouldn t be tested in first place

Some of these slides are taken from this excellent presentation available on line